Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
PESTLE
A framework for viewing the macro environment involving the elements: political, economic, socio-cultural, technological, legal and environmental. Similar to an environmental scanning process, a PEEST analyses procures factual and subjective data on the business environments which a company proposes operating. Using the PEEST framework a business strives to be better aware of what is occurring in the general background recognising the background has consequences in their business strategy.
See also:
PEEST
Background
Business Strategy
Related terms
Attitudinal scaling, Market segmentation, Global brand, Corporate fact sheet, Growth stage, Focused Advertising Sampling Technique (FAST) Marketing, Marketing acronyms, Likert scale, Critical success factors, Boston matrix, Product class, Competitor analysis, Publication planning, Unplanned cannibalisation, Black space ,
COVID-19 Updates and Daily News
Featured jobs
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca's Enhertu receives FDA grant for priority review
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- PM announces plans to lift England’s COVID-19 restrictions
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Developing Innovative Digital Strategies to Engage Patients
- GSK appoint Tony Wood as chief scientific officer
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Cervical Cancer Prevention Month
- Why pharma must get smart in its approach to customer engagement
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- AstraZeneca's Enhertu receives FDA grant for priority review
- AZ’s PNH therapy Ultomiris wins EU backing to expand use for children
- J&J’s COVID-19 booster shows 85% effectiveness in preventing hospitalisation for COVID-19 in study
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
